PLAY PODCASTS
Redefining Obesity Treatment Beyond GLP-1 Limits

Redefining Obesity Treatment Beyond GLP-1 Limits

BioSpace · BioSpace

February 19, 202618m 33s

Audio is streamed directly from the publisher (api.riverside.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, you'll be listening to Jane Hughes, President of R&D and Co Founder of Verdiva Bio, and Jon Rees, CEO and cofounder of MitoRx Therapeutics. We'll discuss next-generation obesity solutions tackling GLP-1's muscle loss and adherence challenges, through innovative muscle preservation, oral administration and combination therapy.


Host

Jennifer Smith-Parker, Director of Insights, BioSpace


Guests

Jane Hughes, President of R&D and Co-founder, Verdiva Bio

Jon Rees, CEO and Co-founder, MitoRx Therapeutics


Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.